StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3089% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie Adjusted Diluted Earnings Per Share — Non-GAAP by Year

Adjusted Diluted Earnings Per Share — Non-GAAP ($/sh) ($)

AbbVie Adjusted Diluted Earnings Per Share — Non-GAAP: $10 in FY2025, down 1.2% from a year earlier.

Latest, FY2025
10
Period ended Dec 31, 2025
Change on a year earlier
-1.2%
10.12 in FY2024
History
5 years
Since FY2021
Sources
1
Proxy Statement (DEF 14A) (abbv-20260508xdef14a.htm, filed 2026-03-23)

Where the FY2025 figure comes from

“|| 2025 | | $ | 32,530,984 | | $ | 57,365,441 | | $ | — | | $ | — | | $ | 12,123,281 | | $ | 24,187,185 | | $ | 259.36 | | $ | 186.74 | | $ | 4,226 | | $ | 10.00”

Source: Proxy Statement (DEF 14A) (abbv-20260508xdef14a.htm, filed 2026-03-23) ↗

Reported in Form 8-K Non-GAAP Reconciliations.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up adjusted Diluted Earnings Per Share — Non-GAAP

Cite this data

StockData. (2026). AbbVie Adjusted Diluted Earnings Per Share — Non-GAAP ($), annual FY2021–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/nongaap-adj-eps

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.